Kenilworth Systems Résultats passés
Passé contrôle des critères 0/6
Kenilworth Systems's earnings have been declining at an average annual rate of -81.2%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 126.3% per year.
Informations clés
-81.2%
Taux de croissance des bénéfices
-26.5%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 8.5% |
| Taux de croissance des recettes | 126.3% |
| Rendement des fonds propres | n/a |
| Marge nette | -1,963.5% |
| Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Pas de mise à jour
Recent updates
Ventilation des recettes et des dépenses
Comment Kenilworth Systems gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 0 | 0 | 0 | 0 |
| 31 Mar 24 | 0 | 0 | 0 | 0 |
| 31 Dec 23 | 0 | 0 | 0 | 0 |
| 30 Sep 23 | 0 | 0 | 0 | 0 |
| 30 Jun 23 | 0 | 0 | 0 | 0 |
| 31 Mar 23 | 0 | 0 | 0 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
| 30 Sep 22 | 0 | 0 | 0 | 0 |
| 30 Jun 22 | 0 | 0 | 0 | 0 |
| 31 Mar 22 | 0 | 0 | 0 | 0 |
| 31 Dec 21 | 0 | 0 | 0 | 0 |
| 30 Sep 21 | 0 | 0 | 0 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Des revenus de qualité: KENS is currently unprofitable.
Augmentation de la marge bénéficiaire: KENS is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: KENS is unprofitable, and losses have increased over the past 5 years at a rate of 81.2% per year.
Accélération de la croissance: Unable to compare KENS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: KENS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Rendement des fonds propres
ROE élevé: KENS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.